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The clinical and pathological features of 20 patients with coexistent squamous cell carcinoma 
and adenocarcinoma of the uterine cervix have been analyzed. Various combinations of 
in situ and invasive carcinomas were found. Located adjacent to each other and at times 
intermingling, these lesions probably originated from the subcolumnar reserve cells of the 
transformation zone. They are early lesions and may be precursors of adenosquamous and 
mucoepidermoid carcinomas of the cervix. The diagnosis of these double carcinomas 
depends upon being aware that the two entities may coexist in the same cervix. Treatment 
is conventional, and the prognosis is not worsened by the presence of the two types of 
neoplasms. 
INTRODUCTION 
The simultaneous occurrence of squamous cell carcinoma (SCC) and adeno- 
carcinoma (ADC) of the uterine cervix has been infrequently reported [l-5]. 
This combination is the rarest and the most unusual form of cervical carcinoma. 
Melnick et al. [l] first reported such cases in 1957; Dougherty and Cotten [3] 
grouped them as combined or “mixed” carcinomas, and Abel1 [6] classified them 
as a histologically distinct type of cervical carcinoma. The histogenesis of syn- 
chronous XC and ADC of the cervix remains speculative. Some authors have 
suggested that they are two separate diseases and that their combined presence 
is coincidental [3], whereas others [4,6] believe that they arise from a common 
cell line, most likely the multipotential subcylindrical or reserve cells of the 
transformation zone. This study pertains to a clinical and pathological analysis 
of such patients diagnosed in one institution over a 27-year period. 
MATERIALS AND METHODS 
From January 1950 through December 1976, 502 patients with ADC and 2175 
patients with SCC of the cervix, including their in situ variants, were treated at 
the University of Michigan Hospital. Twenty of these patients were identified 
from the files of the Tumor Registry as having synchronous SCC and ADC. We 
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have studied their presenting symptoms and signs, the diagnostic methods that 
were used, and the treatment that was given; we also made note of any hormonally 
related etiologic factors. We reviewed the histopathological sections and completed 
a follow-up of the patients through January 1981. Cases of adenosquamous and 
mucoepidermoid carcinoma of the cervix were excluded from the study. 
The pathological identification was made on the basis of the presence of two 
morphologically distinct carcinomas in separate locations in the cervix. Furthermore, 
when there was early intermingling of the two components, a morphological 
transition from one form to another had to be absent, and the architectural 
distinctiveness of each component had to be preserved. 
RESULTS 
Three categories of coexistent XC and ADC were recognized: XC and ADC 
in situ, XC and ADC where one component was in situ and the other was 
invasive, and SCC and ADC where both components were invasive (Table 1). 
Five patients had simultaneous SCC and ADC in situ (Fig. 1). Their average 
age was 35.2 years and their mean parity was 1.4. Symptoms and signs were 
nonspecific. Three patients had a diagnostic cone biopsy because of an abnormal 
cervical smear; the fourth case was identified by biopsies of an ulcerated area 
on the cervix. All of these four patients subsequently underwent hysterectomy. 
The specimens showed no residual carcinoma in one, and residual SCC and 
ADC in situ in another; the remaining two patients each had residual SCC and 
ADC in situ. The fifth case was diagnosed incidentally following an exenteration 
procedure for a recurrent vulvar carcinoma. All patients are alive with no apparent 
disease 5-17 years after treatment. One patient, however, developed SCC in 
situ of the upper vagina which was surgically excised. 
Two patients had simultaneous ADC in situ and invasive SCC diagnosed by 
cone biopsy because of abnormal cervical smears. In both, no clinically apparent 
lesion was recorded. One patient was treated by irradiation; the other underwent 
radical hysterectomy. In the latter patient, both the cone biopsy and the hys- 
terectomy specimens showed areas of SCC in situ and invasive SCC accompanied 
by foci of ADC in situ. The patient died of recurrent carcinoma 3 years later. 
The other patient developed SCC of the vulva 10 years later and is alive 2 years 
after radical vulvectomy. 
Five patients had synchronous SCC in situ and invasive ADC (Fig. 2). Their 
average age was 53 years and mean parity was 4.6. A history of prior use of 
oral contraceptives was elicited in one patient. Four patients had abnormal 
TABLE 1 
TYPES OF COEXISTENT SQUAMOUS CELL CARCINOMA AND ADENOCARCINOMA OF THE CERVIX 
Squamous carcinoma and adenocarcinoma in situ 
Mixed carcinoma in situ and invasive carcinoma 
Adenocarcinoma in situ and invasive XC 
Squamous carcinoma in situ and invasive ADC 
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FIG. 1. (A) Squamous cell carcinoma in situ (H&E, x235). (B) Adenocarcinoma in situ (H&E, 
x 200). 
cervical smears only. The diagnosis of double neoplasms was made by cone 
biopsy in three cases and by direct biopsies in the other. The fifth patient had 
an initial cone biopsy which showed invasive ADC; however, subsequent radical 
hysterectomy also revealed a distinct focus of XC in situ bordering the invasive 
ADC. The treatment consisted of radical surgery in three and radiotherapy in 
two patients. Follow-up data revealed that one patient died 3 years after initial 
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FIG. 2. (A) Squamous cell carcinoma in siru with crypt involvement (H&E, x 160). (B) Well- 
differentiated, invasive endocervical adenocarcinoma (H&E, x 160). 
treatment due to recurrent disease and that the remaining four patients are alive 
for an average of 10.2 years after treatment. 
Eight patients had synchronous invasive SCC and invasive ADC (Figs. 3 & 4). Their 
average age was 57.3 years and their mean parity was 3.5. One case was diagnosed 
during the first trimester of pregnancy. Some cervices were described as showing 
an “erosion,” an “ulcer,” or a “growth.” In most of the cases, however, cancer 
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was not clinically suspected. Four patients were detected on the basis of an 
abnormal cervical smear. The lesions were diagnosed by cone biopsy in six 
patients and by direct biopsies in two patients. In three patients, areas of SCC 
in situ were also identified in addition to the invasive SCC. The carcinomas were 
confined to the cervix in all except one patient who had evidence of neoplasm 
extending to the pelvic sidewall. One patient was treated by radical hysterectomy, 
the rest by irradiation. Follow-up revealed that two died from the carcinoma, 
one 2 and the other 3-years later; two died from nonrelated diseases, one 10 
and the other 13 years later; and the remaining four are alive with an average 
survival of 9.5 years after treatment. 
DISCUSSION 
It is noteworthy that in all of the cases we analyzed, two distinct foci of origin 
of the carcinomas were demonstrable and that these foci were always adjacent 
to each other. In a few instances, early mingling at the interphase was noted, 
yet separate origins of the two types of neoplasm without any transition could 
still be observed. Such juxtaposition of the two neoplasms and their tendency 
to collide strongly suggest an origin from a common cell type rather than from 
different kinds of progenitor cells. The most likely cell of origin is the subcolumnar 
reserve cell located in the transformation zone. These multipotential cells may 
differentiate into squamous cells or gland cells. 
The absence of any clinical suspicion of cancer in most of the patients with 
the invasive carcinomas, the concomitant presence of the in situ counterpart 
in some of the invasive carcinomas, and the need to rely on cone biopsy for the 
diagnosis suggest that these double carcinomas are usually early lesions. It is 
also possible that such double-primary carcinomas may be the precursor of 
adenosquamous and mucoepidermoid carcinomas. It is postulated that when such 
double lesions remain undetected the two types of carcinomas collide and become 
intimately mixed, which precludes any subsequent identification of two separate 
components. When this happens, adenosquamous carcinoma is likely to be di- 
agnosed or, if there is predominant development of a squamous component with 
the glandular component remaining rather unobtrusively as only mucin-secreting 
cells, a diagnosis of mucoepidermoid carcinoma will be made. 
We suggest, therefore, that double-primary SCC and ADC and adenosquamous 
and mucoepidermoid carcinomas of the cervix are a group of mixed carcinomas 
that originate from the subcolumnar reserve cells of the transformation zone, 
and that the double-primary carcinomas are forerunners of adenosquamous and 
mucoepidermoid carcinomas. 
In carcinoma of the cervix of the mixed variety, the hormonal influence of 
pregnancy or oral contraception has been implicated as causative factors [7]. 
Such possible predisposing factors were recognized in only 2 of the 20 patients 
in this study. 
Simultaneous SCC and ADC of the cervix probably occur more frequently 
than has been realized. In a retrospective review of 230 cases of ADC of the 
cervix, Maier and Norris [5] found coexistent squamous intraepithelial neoplasia 
in 43% of the patients. Similarly, Shingleton et al. [8] found mixtures of invasive 
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FIG. 3. (A) A fragment of the invasive squamous cell carcinoma (H&E, x 160). (B) Invasive 
adenocarcinoma (H&E, X 140). (C) Invasive adenocarcinoma next to a focus of invasive squamous 
cell carcinoma, bottom left (H&E, x 160). 
ADC and invasive SCC in one-third and associated squamous intraepithelial 
neoplasia in one-tenth of 137 patients analyzed with invasive ADC of the cervix. 
When such double lesions occur, they do not influence the mode of treatment; 
however, their detection and analysis should shed more light on the histogenesis 
of cervical carcinoma, particularly of the mixed variety. 
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FIG. 3-Continued. 
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